<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132875">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01996878</url>
  </required_header>
  <id_info>
    <org_study_id>CCH060105</org_study_id>
    <nct_id>NCT01996878</nct_id>
  </id_info>
  <brief_title>Genetic Polymorphism and Parkinson's Disease in Taiwanese</brief_title>
  <official_title>Association Analysis of Single Nucleotide Polymorphisms and the Incidence of Parkinson's Disease in a Hospital-based Case-control Study in Taiwan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhua Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhua Christian Hospital</source>
  <oversight_info>
    <authority>Taiwan: Department of Health</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe and analyze the correlation between Single Nucleotide polymorphisms (SNPs) and
      the incidence of Parkinson's disease in Taiwanese.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2006</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">February 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>single nucleotide polymorphisms in certain candidate genes</measure>
    <time_frame>2 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">334</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>Case (Parkinson's disease patients)</arm_group_label>
    <description>Clinical diagnosis of Parkinson's disease (cases are diagnosed by the presence of at least three of the five following primary signs: rest tremor, bradykinesia, rigidity, impaired postural refluxes, and the presence of a sustained L-dopa response.)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control (Healthy volunteers)</arm_group_label>
    <description>Healthy volunteers without Parkinson's disease</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Collect 10 mL peripheric blood for DNA extraction
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Taiwanese
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Parkinson's disease (case subjects are diagnosed by the
             presence of at least three of the five following primary signs: rest tremor,
             bradykinesia, rigidity, impaired postural refluxes, and the presence of a sustained
             L-dopa response.)

          -  Healthy volunteers without Parkinson's disease

        Exclusion Criteria:

          -  Cases showing atypical features, including multiple system atrophy and progressive
             supranuclear gaze palsy, or secondary causes of Parkinsonism, such as neuroleptic
             drugs, infection, tumor, previous cerebrovascular accident and known toxins
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shey-Lin Wu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chang-Hua Christian Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurology, Chang-Hua Christian Hospital</name>
      <address>
        <city>Chang-Hua</city>
        <zip>500</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 22, 2013</lastchanged_date>
  <firstreceived_date>November 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhua Christian Hospital</investigator_affiliation>
    <investigator_full_name>Shey-Lin Wu</investigator_full_name>
    <investigator_title>Superintedent</investigator_title>
  </responsible_party>
  <keyword>Parkinson's disease</keyword>
  <keyword>Genetic Polymorphism</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
